| Product Code: ETC6184316 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Lumasiran Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Lumasiran Market - Industry Life Cycle |
3.4 Australia Lumasiran Market - Porter's Five Forces |
3.5 Australia Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Australia Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Australia Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Australia Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about rare diseases and genetic disorders in Australia |
4.2.2 Rising government initiatives to improve access to innovative therapies |
4.2.3 Growing collaborations between pharmaceutical companies and research institutions |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval processes for new drugs in Australia |
4.3.2 High cost associated with rare disease treatments |
4.3.3 Limited reimbursement options for patients seeking lumasiran therapy |
5 Australia Lumasiran Market Trends |
6 Australia Lumasiran Market, By Types |
6.1 Australia Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Australia Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Australia Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Australia Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Australia Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Australia Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Australia Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Australia Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Australia Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Australia Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Australia Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Australia Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Australia Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Australia Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Australia Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Australia Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Australia Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Australia Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Australia Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Australia Lumasiran Market Import-Export Trade Statistics |
7.1 Australia Lumasiran Market Export to Major Countries |
7.2 Australia Lumasiran Market Imports from Major Countries |
8 Australia Lumasiran Market Key Performance Indicators |
8.1 Number of patients diagnosed with rare diseases in Australia |
8.2 Research and development investment in genetic disorder treatments |
8.3 Number of clinical trials focusing on rare disease therapies |
9 Australia Lumasiran Market - Opportunity Assessment |
9.1 Australia Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Australia Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Australia Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Australia Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Lumasiran Market - Competitive Landscape |
10.1 Australia Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Australia Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here